SEC Tracker
Get the app
RBOT · XBRL financial data

Vicarious Surgical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (RBOT's year ends in late December)

In thousands of dollarsMar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024†Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025
Research and development13,35612,71413,0408,468*9,96810,92410,8008,463*9,4159,0507,9937,143*
General and administrative6,9997,0786,9115,870*5,0005,5925,7475,536*5,2914,1203,1602,625*
Total operating expenses22,31521,45821,35215,541*16,10917,71317,75514,978*15,74713,51911,5039,258*
Operating income (loss)(22,315)(21,458)(21,352)(15,541)*(16,109)(17,713)(17,755)(14,978)*(15,747)(13,519)(11,503)(9,258)*
Interest income1,4731,044946———802—————
Interest expense11122*————————
Net income (loss)(26,922)(15,334)(15,704)(13,111)*(17,001)(15,205)(17,091)(13,926)*(15,394)(13,215)(11,058)(10,515)*
Earnings per share, basic USD per share(0.21)(0.12)(0.10)(0.07)*(0.10)(2.59)—————(1.57)*
Earnings per share, diluted USD per share(0.21)(0.12)(0.10)(0.07)*(0.10)(2.59)—————(1.57)*
Weighted average shares, basic thousands of shares126,130126,992155,141175,123*175,7095,8735,900—5,9245,9385,9546,699*
Weighted average shares, diluted thousands of shares126,130126,992155,141175,123*175,7095,8735,900—5,9245,9385,9546,699*
  • † Share count changed about 1/30 in the period ending 2024-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (RBOT's year ends in late December)

In thousands of dollarsMar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024†Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025
Cash and cash equivalents54,08332,80759,11352,82238,22220,2507,0699,7372,5993,9103,1642,569
Short-term investments43,48749,97651,07645,35545,90452,98053,79539,36034,76320,05310,2507,223
Prepaid and other current assets——3,2222,7762,9852,7033,1132,6012,2902,1041,6611,792
Total current assets101,41285,281113,411100,95387,11175,93363,97751,69839,65226,06715,07511,584
Property and equipment, net6,4616,2545,8896,4025,8915,3254,8204,4764,1123,7913,4751,268
Right-of-use asset12,07611,87511,66911,45911,24311,02110,79410,56010,32110,0759,8225,764
Total assets121,090104,526132,051119,864105,28693,34780,61667,71955,05240,89029,34719,581
Accounts payable1,9101,5851,5291,2581,2721,3552,4161,1661,021721915894
Accrued liabilities3,8284,9375,2674,9752,7164,6955,0135,2835,5713,0689051,056
Total current liabilities6,6707,4897,8037,2805,0767,1818,6037,6677,8555,0983,1763,904
Lease liability, non-current——14,06013,78513,50313,19812,88612,56712,24111,88911,5305,836
Total liabilities33,36228,83724,17921,89521,27621,48622,73421,02120,97617,82715,2599,740
Accumulated deficit(88,563)(103,897)(119,601)(132,712)(149,713)(164,918)(182,009)(195,935)(211,329)(224,544)(235,602)(246,117)
Total stockholders' equity87,72875,689107,87297,96984,01071,86157,88246,69834,07623,06314,0889,841
Total liabilities and equity121,090104,526132,051119,864105,28693,34780,61667,71955,05240,89029,34719,581
  • † Share count changed about 1/30 in the period ending 2024-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (RBOT's year ends in late December)

In thousands of dollarsMar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024†Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025
Net income (loss)(26,922)(15,334)(15,704)(13,111)*(17,001)(15,205)(17,091)(13,926)*(15,394)(13,215)(11,058)(10,515)*
Stock-based compensation3,2543,324*3,614*3,075*3,0913,066*2,937*2,810*2,7872,196*2,049*1,103*
Depreciation and amortization—————524507——413352—
Net cash from operating activities(18,570)(15,082)*(17,283)*(11,370)*(14,458)(11,021)*(12,689)*(11,788)*(11,768)(13,532)*(10,464)*(9,312)*
Purchases of property and equipment306208*118*1,038*106*—year only50*—year only
Net cash from investing activities(43,828)(6,356)*(644)*5,045*(144)(6,951)*(492)*14,450*4,61314,819*9,692*3,023*
Proceeds from issuing common stock———0*————————
Net cash from financing activities273162*44,233*34*20*0*6*1724*26*5,694*
  • † Share count changed about 1/30 in the period ending 2024-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Vicarious Surgical1,407not reported(6,325)not reported0.6 quarters 10-QMar 31, 2026
Milestone Scientific2,067not reported(585)*88.7M3.5 quarters 10-QJun 30, 2026
Modular Medical3,920not reported(5,972)8.2M0.7 quarters 10-QJun 30, 2026
Nuo Therapeutics449not reported(236)*48.4M1.9 quarters 10-QJun 30, 2026
Alpha Pro Tech18,901not reported2,213*10.2M— 10-QJun 30, 2026
HeartBeam8,722not reported(3,342)*56.3M2.6 quarters 10-QJun 30, 2026
Hyperfine43,4583,904(7,268)*not reported6.0 quarters 10-QJun 30, 2026
Xtant Medical Holdings9,87023,031(7,308)*140.3M1.4 quarters 10-QJun 30, 2026
Vivani Medical19,894not reported(6,035)*90.2M3.3 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.